Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Olbrich

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Science Immunology|January 12, 2024
Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cellsJulian Staniek, Tomas Kalina, Geoffroy Andrieux, et al.
Science (New York, N.Y.)|September 16, 2021
Response to Comments on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections"Timothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
Science (New York, N.Y.)|January 15, 2021
Aberrant type 1 immunity drives susceptibility to mucosal fungal infectionsTimothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITAPeter Olbrich, M Fischer, A Deyà-Martinez, et al.
Science Translational Medicine|September 18, 2024
A deep intronic splice-altering <i>AIRE</i> variant causes APECED syndrome through antisense oligonucleotide-targetable pseudoexon inclusionSebastian Ochoa, Amy P Hsu, Andrew J Oler, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2023
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective studyMarco Fischer, Peter Olbrich, Jérôme Hadjadj, et al.
Frontiers in Immunology|March 31, 2018
Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome RegistryMaria Elena Maccari, Hassan Abolhassani, Asghar Aghamohammadi, et al.
The New England Journal of Medicine|May 29, 2024
The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1Vasileios Oikonomou, Grace Smith, Gregory M Constantine, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2018
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjectsCharlotte Schwab, Annemarie Gabrysch, Peter Olbrich, et al.
Frontiers in Pediatrics|January 9, 2023
Examining the immune signatures of SARS-CoV-2 infection in pregnancy and the impact on neurodevelopment: Protocol of the <i>SIGNATURE</i> longitudinal studyNathalia Garrido-Torres, Lucas Cerrillos, Susana García Cerro, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Science Immunology|January 12, 2024
Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cellsJulian Staniek, Tomas Kalina, Geoffroy Andrieux, et al.
Science (New York, N.Y.)|September 16, 2021
Response to Comments on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections"Timothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
Science (New York, N.Y.)|January 15, 2021
Aberrant type 1 immunity drives susceptibility to mucosal fungal infectionsTimothy J Break, Vasileios Oikonomou, Nicolas Dutzan, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITAPeter Olbrich, M Fischer, A Deyà-Martinez, et al.
Science Translational Medicine|September 18, 2024
A deep intronic splice-altering <i>AIRE</i> variant causes APECED syndrome through antisense oligonucleotide-targetable pseudoexon inclusionSebastian Ochoa, Amy P Hsu, Andrew J Oler, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2023
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective studyMarco Fischer, Peter Olbrich, Jérôme Hadjadj, et al.
Frontiers in Immunology|March 31, 2018
Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome RegistryMaria Elena Maccari, Hassan Abolhassani, Asghar Aghamohammadi, et al.
The New England Journal of Medicine|May 29, 2024
The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1Vasileios Oikonomou, Grace Smith, Gregory M Constantine, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2018
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjectsCharlotte Schwab, Annemarie Gabrysch, Peter Olbrich, et al.
Frontiers in Pediatrics|January 9, 2023
Examining the immune signatures of SARS-CoV-2 infection in pregnancy and the impact on neurodevelopment: Protocol of the <i>SIGNATURE</i> longitudinal studyNathalia Garrido-Torres, Lucas Cerrillos, Susana García Cerro, et al.
Pageof 6